Larimar Therapeutics, Inc.
corporate_fare Company Profile
Larimar Therapeutics, Inc. (NASDAQ:LRMR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for LRMR at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Deerfield Management Makes $25M Open Market Purchase in Larimar Therapeutics
- Larimar Therapeutics Prices $100M Public Offering at 16% Discount to Fund Breakthrough Therapy Development
- Larimar Therapeutics Launches $75M Public Offering to Fund Breakthrough Therapy Development Amidst Going Concern Risk
- FDA Grants Breakthrough Therapy Designation for Nomlabofusp in Friedreich's Ataxia, De-risking Regulatory Path
- Larimar Therapeutics Restructures Major Investor's Common Stock into Convertible Preferred Shares
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$165.67M
Op. Cash Flow
-$113.2M
Free Cash Flow
-$113.29M
Operating Income
-$172.5M
Cash & Equivalents
$85.41M
Debt / Equity
0.00×
Shares Outstanding
83.09M sh
Source: 10-K · filed 2026-03-19 · accession 0001193125-26-115878
show_chartPrice Chart
Loading chart...
feed LRMR - Filings & News (Page 2)
LRMR
Mar 02, 2026, 7:46 PM EST
Price at Filing:
$5.48
Real-time Price:
$2.88
Change:
-$2.60 (-47%)
Market Cap:
$328.553M
LRMR
Feb 26, 2026, 4:20 PM EST
Price at Filing:
$5.80
Real-time Price:
$2.88
Change:
-$2.92 (-50%)
Market Cap:
$328.553M
LRMR
Feb 25, 2026, 4:05 PM EST
Price at Filing:
$5.57
Real-time Price:
$2.88
Change:
-$2.69 (-48%)
Market Cap:
$328.553M
LRMR
Feb 24, 2026, 7:02 AM EST
Price at Filing:
$3.11
Real-time Price:
$2.88
Change:
-$0.2325 (-7%)
Market Cap:
$328.553M
LRMR
Jan 22, 2026, 7:00 AM EST
Price at Filing:
$3.37
Real-time Price:
$2.88
Change:
-$0.4925 (-15%)
Market Cap:
$328.553M
LRMR
Jan 12, 2026, 4:18 PM EST
Price at Filing:
$3.25
Real-time Price:
$2.88
Change:
-$0.3725 (-11%)
Market Cap:
$328.553M